Expression of estrogen receptors α and β, and progesterone receptors A and B in human mucinous carcinoma of the endometrium

Anticancer Research

Volumn 27, Issue 4 A, 2007, Pages 2027-2033

  Shabani, Naim ^a,b   Mylonas, Ioannis ^b   Jeschke, Udo ^b   Thaqi, Agim ^b   Kuhn, Christina ^b   Puchner, Thomas ^a   Friese, Klaus ^b  

^a Landes Krankenhaus Schärding   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

Estrogen receptor (ER); Mucinous endometrial carcinoma; Progesterone receptor (PR)

Indexed keywords

ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; PROGESTERONE RECEPTOR A; PROGESTERONE RECEPTOR B;

CANCER GRADING; CONFERENCE PAPER; CONTROLLED STUDY; ENDOMETRIUM CARCINOMA; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MUCINOUS CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SCORING SYSTEM;

ADENOCARCINOMA, MUCINOUS; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; TUMOR MARKERS, BIOLOGICAL;

EID: 34250736704     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (32)

1. Mylonas I JU, Shabani N, Kuhn C, Balle A, Kriegel S, Kupka MS and Friese K: Immunohistochemical analysis of estrogen receptor alpha, estrogen receptor beta and progesterone receptor in normal human endometrium. Acta Histochem 106(3): 245-252, 2004.
2. Melhem MF and Tobon H: Mucinous adenocarcinoma of the endometrium: a clinicopathological review of 18 cases. Int J Gynecol Pathol 6: 347-355, 1987.
3. Snijders MP, de Goeij AF, Koudstaal J, Thunnissen EB, de Haan J and Bosman FT: Oestrogen and progesterone receptor immunocytochemistry in human hyperplastic and neoplastic endometrium. J Pathol 166(2): 171-177, 1992.
4. Lessey BA: Embryo quality and endometrial receptivity: lessons learned from the ART experience. J Assist Reprod Genet 15: 173-176, 1998.
5. Sherman ME: Theories of endometrial carcinogenesis: a multidisciplinary approach. Mod Pathol 13: 295-308, 2000.
6. Leslie KK, Stein MP, Kumar NS, Dai D, Stephens J, Wandinger-Ness A and Glueck DH: Progesterone receptor isoform identification and subcellular localization in endometrial cancer. Gynecol Oncol 96: 32-41, 2005.
7. Hanekamp EE, Kuhne LM, Grootegoed JA, Burger CW and Blok LJ: Progesterone receptor A and B expression and progestagen treatment in growth and spread of endometrial cancer cells in nude mice. Endocr Relat Cancer 11: 831-841, 2004.
8. Archer DF: Neoplasia of the female reproductive tract: effects of hormone therapy. Endocrine 24: 259-263, 2004.
9. Snijders MP, de Goeij AF, Koudstaal J, Thunnissen EB, de Haan J and Bosman FT: Oestrogen and progesterone receptor immunocytochemistry in human hyperplastic and neoplastic endometrium. J Pathol 166: 171-177, 1992.
10. Fischer B, Redmond C, Fisher ER and Caplan R: Relative worth of estrogen or progesterone receptor and pathologic characteristics of differentiation as indicators of prognosis in node negative breast cancer patients: findings from National Surgical Adjuvant Breast and Bowel Project Protocol B-06. J Clin Oncol 6: 1076-1087, 1988.
11. Creasman WT: Prognostic significance of hormone receptors in endometrial cancer. Cancer 71: 1467-1470, 1993.
12. Creasman WT: Adenocarcinoma of the uterine corpus. Curr Opin Obstet Gynecol 5: 80-83, 1993.
13. Fujimoto J, Sakaguchi H, Aoki I, Toyoki H and Tamaya T: Clinical implications of the expression of estrogen receptor-alpha and -beta in primary and metastatic lesions of uterine endometrial cancers. Oncology 62: 269-277, 2002.
14. Mylonas I, Jeschke U, Shabani N, Kuhn C, Kriegel S, Kupka MS and Friese K: Normal and malignant human endometrium express immunohistochemically estrogen receptor alpha (ER-alpha), estrogen receptor beta (ER-beta) and progesterone receptor (PR). Anticancer Res 25: 1679-1686, 2005.
15. Remmele W and Stegner HE: Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue. Pathologe 8: 138-140, 1987.
16. Mylonas I, Speer R, Makovitzky J, Richter DU, Briese V, Jeschke U and Friese K: Immunohistochemical analysis of steroid receptors and glycodelin A (PP14) in isolated glandular epithelial cells of normal human endometrium. Histochem Cell Biol 114: 405-411, 2000.
17. Lax SF PE, Ronnett BM and Kurman RJ: Comparison of estrogen and progesterone receptor, Ki-67, and p53 immunoreactivity in uterine endometroid carcinoma and endometroid carcinoma with squamous, mucinous, secretory, and ciliated cell diferentiation. Hum Pathol 29: 924-931, 1998.
18. Carcangiu ML, Chambers JT, Voynick IM, Pirro M and Schwartz PE: Immunohistochemical evaluation of estrogen and progesterone receptor content in 183 patients with endometrial carcinoma. Part I: Clinical and histologic correlations. Am J Clin Pathol 94: 247-254, 1990.
19. Mylonas I, Jeschke U, Shabani N, Kuhn C, Kunze S, Dian D, Friedl C, Kupka MS and Friese K: Steroid receptors ERalpha, ERbeta, PR-A and PR-B are differentially expressed in normal and atrophic human endometrium. Histol Histopathol 22(2): 169-176, 2007.
20. Kuiper GG, Enmark E, Pelto-Huikko M, Nilsson S and Gustafsson JA: Cloning of a novel estrogen receptor expressed in rat prostate and ovary. Proc Natl Acad Sci USA 93: 5925-5930, 1996.
21. Chu S, Mamers P, Burger HG and Fuller PJ: Estrogen receptor isoform gene expression in ovarian stromal and epithelial tumors. J Clin Endocrinol Metab 85(3): 1200-1205, 2000.
22. Saegusa M and Okayasu I: Changes in expression of estrogen receptors alpha and beta in relation to progesterone receptor and pS2 status in normal and malignant endometrium. Jpn J Cancer Res 91(5): 510-518, 2000.
23. Emons G, Fleckenstein G, Hinney B, Huschmand A and Heyl W: Hormonal interactions in endometrial cancer. Endocr Relat Cancer 7: 227-242, 2000.
24. Kumar NS, Richer J, Owen G, Litman E, Horwitz KB and Leslie KK: Selective down-regulation of progesterone receptor isoform B in poorly differentiated human endometrial cancer cells: implications for unopposed estrogen action. Cancer Res 58: 1860-1865, 1998.
25. Smid-Koopman E, Kuhne LC, Hanekamp EE, Gielen SC, De Ruiter PE, Grootegoed JA, Helmerhorst TJ, Burger CW, Brinkmann AO, Huikeshoven FJ and Blok LJ: Progesterone-induced inhibition of growth and differential regulation of gene expression in PRA- and/or PRB-expressing endometrial cancer cell lines. J Soc Gynecol Investig 12: 285-292, 2005.
26. Dai D, Wolf DM, Litman ES, White MJ and Leslie KK: Progesterone inhibits human endometrial cancer cell growth and invasiveness: down-regulation of cellular adhesion molecules through progesterone B receptors. Cancer Res 62: 881-886, 2002.
27. Fujimoto J, Ichigo S, Hori M, Nishigaki M and Tamaya T: Expression of progesterone receptor form A and B mRNAs in gynecologic malignant tumors. Tumour Biol 16: 254-260, 1995.
28. Arnett-Mansfield RL, deVazio A, Wain GV, Jaworski RC, Byth K, Mote PA and Clarke CL: Relative expression of progesterone receptors A and B in endometrioid cancers of the endometrium. Cancer Res 61: 4576-4582, 2001.
29. Fujimoto J, Sakaguchi H, Aoki I, Khatun S, Toyoki H and Tamaya T: Steroid receptors and metastatic potential in endometrial cancers. J Steroid Biochem Mol Biol 75: 209-212, 2000.
30. Moutsatsou P and Sekeris CE: Estrogen and progesterone receptors in the endometrium. Ann NY Acad Sci 816: 99-115, 1997.
31. Fukuda K, Mori M, Uchiyama M, Iwai K, Iwasaka T and Sugimori H: Prognostic significance of progesterone receptor immunohistochemistry in endometrial carcinoma. Gynecol Oncol 69: 220-225, 1998.
32. Nordstrom B, Strang P, Lindgren A, Bergstrom R and Tribukait B: Carcinoma of the endometrium: do the nuclear grade and DNA ploidy provide more prognostic information than do the FIGO and WHO classifications? Int J Gynecol Pathol 15(3): 191-201, 1996.